Low vitamin D use in patients on enzyme-inducing antiseizure drugs raises concerns

Enzyme-inducing antiseizure drugs (ASDs) are associated with increased odds of incident osteoporosis or osteopenia, but vitamin D supplementation is underutilized, according to a study presented at the annual meeting of the American Neurological Association, held from Oct. 17 to 20 in San Diego.

Read it at Medical Xpress ↗

← Front page